Therefore, the aims of the present studies were (1) to analyze the expression of HER2 in canine mammary carcinoma and its correlation with the amplification status; (2) to investigate the correlation of these results with clinicopathological parameters in canine species. This evidence concerns the gene ERBB2 and breast carcinoma.